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Actions of hepatocyte growth factor as a local modulator in the kidney:
Potential role in pathogenesis of renal disease. Endothelial cells are
known to secrete various vasoactive substances that may control mesangial
cell growth, whereas mesangial cells also secrete various growth factors
and cytokines that may regulate endothelial cells. Therefore, it is apparent
that cell-cell interactions among renal cells are important in the control of
renal function. Indeed, co-culture of endothelial cells with mesangial cells
resulted in a significant decrease in mesangial cell growth. However, the
exact mechanisms of maintaining the cell-cell interactions are not yet
understood. We have focused on the role of hepatocyte growth factor
(HGF) in the regulation of cell-cell interactions, since HGF has been
reported to have many organ protective functions in the kidney. Our
present data demonstrated that addition of recombinant HGF (rHGF)
stimulated DNA synthesis and growth of endothelial cells in a dose-
dependent manner. However, there was no stimulatory effect of rHGF on
the growth of mesangial cells in the time and dose-dependent manner.
Therefore, we examined the presence of the local renal HGF system and
its potential role in renal disease. The presence of secreted local HGF was
observed in the conditioned medium from endothelial and mesangial cells.
The presence of HGF mRNA was also detected in endothelial and
mesangial cells. Interestingly, the specific receptor of HGF, c-met, was
also expressed in both cells. Next, regulation of local HGF secretion was
studied under stimulation with rHGF, angiotensin (Ang) II, and trans-
forming growth factor (TGF)-b. Of importance, rHGF significantly stim-
ulated local HGF secretion from mesangial cells by positive feedback. In
contrast, TGF-b significantly decreased HGF secretion in mesangial cells
and endothelial cells. Angiotensin II also significantly decreased local
HGF production in mesangial cells in a dose-dependent manner. Finally,
the effect of local HGF production from mesangial cells was studied using
a co-culture system. Co-culture of mesangial cells with endothelial cells
resulted in a significant increase in number of endothelial cells, which was
abolished by co-incubation with neutralizing anti-HGF antibody. Overall,
these results demonstrated the local production of HGF, which has
stimulatory effects on growth of endothelial cells, but not mesangial cells.
Local HGF secretion from mesangial cells may maintain the growth of
endothelial cells. Negative regulation of local HGF production by Ang II
and TGF-b may play an important role in the pathogenesis of renal
disease. Taken together, dysfunction of cell-cell regulation in the kidney
due to decreased local HGF production may be an initial trigger for the
development of renal disease such as glomerulonephritis.
Endothelial cells are known to secrete various vasoactive sub-
stances. Recently, it has been hypothesized that endothelial cells
may also modulate mesangial cell growth, because many anti-
proliferative factors such as nitric oxide (NO) and vascular
natriuretic peptides are secreted by endothelial cells [1–3]. It is
apparent that dysfunction of endothelial cells may promote
abnormal mesangial cell growth such as in glomerulonephritis
[4–6]. Given the importance of endothelial cells, we hypothesize
that the rapid regeneration of endothelial cells not accompanied
by mesangial cell growth may have therapeutic potential in
abnormal mesangial cell growth. In contrast, mesangial cells also
secrete various growth factors and cytokines that may regulate
endothelial cells. Therefore, it is apparent that cell-cell interac-
tions among renal cells are important in control of renal function.
However, the exact mechanisms of maintaining the cell-cell
interactions in the kidney are not yet understood. From this
viewpoint, we have focused on the potential role of hepatocyte
growth factor. Hepatocyte growth factor (HGF) was initially
identified as the most potent growth factor of hepatocytes [7, 8],
and is well known as a mesenchyme-derived pleiotropic factor that
regulates cell growth, cell motility, and morphogenesis of various
types of cells. HGF is also considered as a humoral mediator of
epithelial-mesenchymal interactions responsible for morphogenic
tissue interactions during embryonic development and organo-
genesis [9–12]. Recent studies suggest that HGF has many actions
on the cells of other target organs including the kidney [13–16].
For example, administration of recombinant HGF promoted the
regeneration of epithelial cells injured by anti-tumor drugs [14].
However, little is known about the local HGF system in the
kidney. In this study, we evaluated the presence of a local renal
HGF system and its potential role in renal disease.
METHODS
Cell culture
Rat mesangial cells were kindly donated by Kirin Brewery Co.,
Ltd. (Tokyo, Japan). Rat aortic endothelial cells were obtained
enzymatically from 12-week-old Sprague-Dawley rats [17]. Bovine
glomerular endothelial cells (GEN-T) were purchased from
ATCC (American Tissue Culture Collection). Human mesangial
cells (Cryo NHMC; passage 5) and human aortic endothelial cells
(passage 5) were obtained from Clonetics Corp. (San Diego, CA,
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USA), and cultured in modified MCDB131 medium supple-
mented with 5% fetal calf serum, 100 U/ml penicillin, 100 mg/ml
streptomycin, 10 ng/ml epidermal growth factor, 2 ng/ml bFGF
and 1 mM dexamethasone in the standard fashion. All the cells
were used within passages 5 to 6. Rat mesangial cells were
maintained in Dulbecco’s modified Eagle’s medium (DMEM)
supplemented with 10% fetal calf serum, 100 U/ml penicillin and
100 mg/ml streptomycin. Glomerular endothelial cells (GEN-T)
were maintained in RPMI 1640 medium supplemented with 10%
fetal calf serum, 100 U/ml penicillin and 100 mg/ml streptomycin.
Cells were incubated at 37°C in a humidified atmosphere of 95%
air-5% CO2 with media changes every two days. These cells
showed the specific characteristics of mesangial and endothelial
cells, respectively, on immunohistochemical examination and
morphological observations. Briefly, endothelial cells tested pos-
itive for factor VIII antigen and for uptake of di-acetylated LDL.
In contrast, mesangial cells also tested positive for a-actin, and
negative for expression of factor VIII antigen. All cells except
GEN-T were used within passages 5 to 6.
Co-culture
Co-culture cells were seeded onto cell culture inserts (3.0 mM
pore size; Becton Dickinson & Company, Belgium) and were
grown in 10% DMEM. Cells were seeded onto 6-well or 24-well
plates (Becton Dickinson), maintained in 10% fetal calf serum
and placed in defined serum-free medium (DSF) for 48 hours
post-confluence. The DSF containing insulin (5 3 1027 M),
transferrin (5 mg/ml), and ascorbate (0.2 mM) maintains in a
noncatabolic state, as previously reported [18]. At confluence, the
inserts containing co-cultured cells were put into the wells con-
taining the quiescent cells [19]. Endothelial cells were co-cultured
for 48 hours with mesangial cells in DSF and cell numbers were
assessed by cell counting assay.
Cell counting assay
In the preparation of experiments for determination of cell
count, the cells were grown to 70% confluence in 96-well culture
plates (Becton Dickinson). After 70% confluence, the medium
was changed to fresh DSF. The cells were then incubated over-
night. On day 1, the medium was again changed to fresh DSF
containing HGF (10 ng/ml), basic FGF (10 ng/ml), VEGF (10
ng/ml), TGF-b (10 ng/ml) or vehicle. On day 3, the medium was
again changed to fresh DSF containing growth factor or vehicle.
On day 4, an index of cell proliferation was determined using
WST-cell counting kit (Wako, Osaka, Japan). Tetrazolium salt
has been used to develop a quantitative colorimetric assay for cell
growth. For this purpose, 3-(4,5-dimethylthiazol-2-yl)-2,5,-diphe-
nyl tetrazolium bromide (MTT) is widely used [20]. In this study,
we used an alternative of MTT, that is, sulfonated tetrazolium
salt, 4-[3-(4-iodophenyl]-2-(4-nitrophenyl)-2H-5-tetrazolio]-1,3-
benzene disulfonate (WST-1), since this compound produces a
highly water-soluble formazan dye, which makes the assay proce-
dure easier to perform [21–25]. Briefly, 16.3 mg WST-1 and 0.2
mM 1-methoxy-5-methyl-phenazinium methylsulfate were dis-
solved in 20 mM HEPES buffer (pH 7.4). Then, 10 ml of the
reaction solution was immediately added to 100 ml culture me-
dium per well and the cells were then incubated for an additional
two hours. The plate were read on a Bio-Rad Model 3550
Microplate reader, using a test wavelength of 450 nm, and a
reference wavelength of 650 nm. We confirmed that serum-
stimulated increase in cell number is associated with increased
absorbance at 450 nm.
Mitogenic action of conditioned medium from mesangial cells
The ability of conditioned medium to increase cell growth in a
paracrine fashion was examined.
Protocol 1. Conditioned medium, collected from rat mesangial
cells after confluence, was diluted 1:1 with fresh medium. Quies-
cent endothelial cells (seeded on 24-well plates and placed in
medium with 0.5% FCS for 48 hr after 80% confluence) were
treated with the diluted conditioned medium. Three days later,
cell growth assay was performed.
Protocol 2. Mesangial cells were treated with vehicle or human
recombinant HGF (10 ng/ml) for 48 hours after confluence before
collecting conditioned medium. After washing cells with DSF five
times, medium was changed to fresh medium. Then cells were
incubated for 48 hours to collect conditioned medium. Condi-
tioned medium, collected from rat mesangial cells, was diluted 1:1
with fresh medium. Quiescent endothelial cells (seeded on 24-well
plates and placed in medium with 0.5% FCS for 48 hr after 80%
confluence) were treated with diluted conditioned media. Three
days later, cell growth assay was performed. To avoid the contam-
ination of recombinant HGF, HGF concentration in the condi-
tioned medium was measured by EIA using human specific
anti-HGF antibody, and human immunoreactive HGF could not
be detected.
Reverse transcription-polymerase chain reaction
RNA was extracted from each cell type by RNAzol (Tel-Test
Inc., TX, USA), after reaching confluence under serum stimula-
tion. Levels of HGF and its receptor (c-met) mRNAs were
measured by reverse transcription-polymerase chain reaction
(RT-PCR) [26]. The HGF 59 primer (nucleotides 1409-1426 of
human sequence) was 59-ATG-CTC-ATG-GAC-CCT-GGT-39;
the 39 primer (nucleotides 1797-1814 of human sequence) was
59-GCC-TGG-CAA-GCT-TCA-TTA-39 (423 bp). The 59 primer
2788-2811 complementary to the rat c-met gene was 59-CAG-
TGA-TGA-TCT-CAA-TGG-GCA-AT-39; the 39 primer 3492-
3504 was 59-AAT-GCC-CTC-TTC-CTA-TGA-CTT-C-39. Ex-
treme care was taken to avoid contamination of tissue samples
with trace amounts of experimental RNA. Aliquots of RNA (0.5
mg) derived from cultured cells were amplified simultaneously by
PCR (35 cycles), with the same reagents, by individuals who were
blinded to the identity of the samples, and compared with a
negative control (primers without RNA). Amplification products
were electrophoresed through 2% agarose gel and stained with
ethidium bromide. To ensure that the RT-PCR amplified product
reflects transcribed HGF and c-met RNAs without significant
DNA contamination, RNA samples treated with RNase A or
amplified without reverse transcriptase were amplified simulta-
neously as negative controls. These samples did not result in a
visual band. Moreover, PCR products were cut by restriction
enzymes, and the fragments were identical to the theoretical
bands. At least three aliquots of each DNA and RNA sample were
subjected to separate PCR amplification in all experiments.
Measurement of hepatocyte growth factor in conditioned
medium
Rat mesangial and endothelial cells were seeded on 6-well
plates (Corning, NY, USA) at a density of 5 3 104 cells/cm2 and
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cultured for 24 hours. After replacing the medium with fresh DSF
and following culture for 24 hours, the concentration of HGF
in the medium was determined by an enzyme immunoassay
using anti-rat HGF or anti-human HGF antibodies, as de-
scribed previously [22, 27, 28]. Rabbit anti-rat or anti-human
HGF IgG was used to coat a 96-well plate (Corning) at 4°C for
15 hours. After blocking with 3% bovine serum albumin in
phosphate-buffered saline (PBS), conditioned medium was
added to each well, and the preparation was incubated for two
hours at 25°C. Wells were washed three times with PBS
containing 0.025% Tween 20 (PBS-Tween), then biotinylated
rabbit anti-rat HGF IgG or anti-human HGF IgG was added
and the preparation was incubated for two hours at 25°C. After
washing with PBS-Tween, wells were incubated with horserad-
ish peroxidase-conjugated streptoavidin-biotin complex in
PBS-Tween. The enzyme reaction was initiated by adding
substrate solution composed of 2.5 mg/ml o-phenylenediamine,
100 mM sodium phosphate, 50 mM citric acid, and 0.015%
H2O2. The enzyme reaction was halted by adding 1 M H2SO4,
and absorbance at 490 nm was measured. This EIA specifically
detects rat or human HGF, because of lack of cross-reactivity
of these antibodies [21, 22, 27, 28].
Fig. 1. Effect of exogenously added rat recombinant hepatocyte growth factor (HGF) on the number of bovine glomerular endothelial cells (GEN-T)
(A) and rat vascular endothelial cells (B). N 5 8 per group. Abbreviations are: DSF, vehicle added to cells; HGF, rat recombinant HGF (10 ng/ml)
added to cells. **P , 0.01 versus DSF. (C) Effect of exogenously added rat recombinant HGF on number of rat mesangial cells. N 5 8 per group.
Abbreviations are: DSF, vehicle added to cells; HGF, rat recombinant HGF (10 ng/ml) added to cells; VEGF, human recombinant VEGF (10 ng/ml)
added to cells; TGF, recombinant TGF-b (10 ng/ml) added to cells; FGF, recombinant basic FGF (10 ng/ml) added to cells; SERUM, 10% serum added
to cells. *P , 0.05, **P , 0.01 versus DSF. (D) Effect of exogenously added human recombinant HGF on number of human mesangial cells at 48 (o),
96 (3) and 144 (u) hours. N 5 8 per group. Abbreviations are: DSF, vehicle added to cells; HGF, human recombinant HGF (0.1 to 100 ng/ml) added
to cells; CS, 10% serum added to cells. **P , 0.01, ##P , 0.01, $$P , 0.01 versus DSF.
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Effect of neutralizing anti-hepatocyte growth factor antibody
For each of the antibodies, the IgG fraction (purified with
Protein A-agarose) was able to neutralize a biological activity of
10 ng/ml HGF, at a concentration of 10 mg/ml [28]. Neutralizing
anti-rat HGF antibody can attenuate only effects of rat and
murine HGF, but not human and bovine HGF. In contrast,
anti-human HGF can attenuate only human HGF, but not
murine, rat and bovine HGF. Normal rabbit serum IgG fraction
(10 mg/ml) was employed as a control. Numbers of endothelial
cells were counted in the following groups [22]: Group 1, by using
an anti-HGF antibody (final 10 mg/ml); group 2, using normal IgG
(final 10 mg/ml).
Materials
Human and rat recombinant HGF were purified from the
culture medium of Chinese hamster ovary cells or C-127 cells,
respectively, transfected with expression plasmid containing hu-
man or rat HGF cDNA [29–31]. Transforming growth factor beta
(TGF-b), angiotensin II, VEGF and basic FGF were obtained
from Biosource (Camarillo, CA, USA).
Statistical analysis
All values are expressed as mean 6 SEM. Analysis of variance
with subsequent Bonferroni’s/Dunnet test was employed to deter-
mine the significance of differences in multiple comparisons.
Values of P , 0.05 were considered statistically significant.
RESULTS
Effect of recombinant hepatocyte growth factor on the growth
of renal cells
In this study, we hypothesized that endothelial cells secrete
many growth inhibitory factors against growth of mesangial cells.
Indeed, co-culture of glomerular endothelial cells (GEN-T) with
rat mesangial cells resulted in a significant decrease in number
of mesangial cells. Therefore, it is important to find specific
growth factors for endothelial cell growth, but not mesangial cell
growth. With this aim, we focused on HGF as a candidate,
because HGF is known to be a unique growth factor [9–16].
Initially, we examined the effect of HGF on glomerular endothe-
lial cell growth. As shown in Figure 1 A and B, rat recombinant
HGF stimulated the growth of bovine glomerular endothelial
cells (GEN-T) as well as rat vascular endothelial cells. The
specificity of the stimulatory effects of HGF was confirmed by
the blockade of cell growth by anti-HGF specific antibody (data
not shown). Human recombinant HGF also stimulated DNA
synthesis in human aortic endothelial cells in a dose-dependent
manner (Fig. 2). On the other hand, rat recombinant HGF had
no mitogenic actions on rat mesangial cells (Fig. 1C). Similarly,
human recombinant HGF did not stimulate the growth of
human mesangial cells (NHMC) in the time and dose depen-
dent manner (Fig. 1D). These results indicate that HGF can
exert stimulatory effects on growth of endothelial cells, but not
mesangial cells.
Presence of local hepatocyte growth factor system in renal cells
The presence of HGF mRNA was detected in endothelial cells
(rat endothelial cells and GEN-T) and mesangial cells (rat and
human) by RT-PCR. As well as rat renal cells, the presence of
HGF mRNA was detected in human mesangial cells (NHMC)
(Fig. 3). Similarly, the presence of its specific functional receptor
(c-met) was readily detected by RT-PCR in endothelial, rat
mesangial and human mesangial cells (NHMC) (Fig. 4). The
secretion of HGF was also confirmed by ELISA in the condi-
tioned medium from rat aortic endothelial cells and rat mesangial
cells (endothelial cells, 1.16 6 0.01 ng/ml; mesangial cells, 0.23 6
0.01 ng/ml).
Therefore, we examined the regulation of local HGF secretion
from renal cells. The effects of Ang II and TGF-b on local HGF
production were studied, as Ang II and TGF-b have been
postulated as potential triggers of renal diseases such as glomer-
ulonephritis [32–37]. Of importance, TGF-b and Ang II signifi-
cantly decreased HGF secretion in rat mesangial cells (P , 0.05;
Fig. 5A). The inhibitory effect of Ang II and TGF-b in local HGF
production was observed in a dose-dependent manner (data
not shown). We also examined if HGF itself affects local HGF
production in rat mesangial cells. Interestingly, addition of recom-
binant human HGF itself significantly stimulated local HGF
secretion from rat mesangial cells by positive feedback (Fig. 5B).
To confirm the auto-induction of HGF by recombinant HGF,
we examined the mitogenic action of conditioned medium from
rat mesangial cells stimulated by vehicle and recombinant rat
HGF prior to collection (see Methods, Protocol 2). Addition of
conditioned medium from mesangial cells that were pre-incu-
bated with recombinant HGF for 48 hours before collecting the
medium resulted in a significant increase in the number of
endothelial cells as compared to conditioned medium from mes-
angial cells pre-incubated with vehicle for 48 hours (vehicle
0.630 6 0.012 vs. HGF 0.803 6 0.026; OD 450 nm; P , 0.01). In
human mesangial cells (NHMC), Ang II as well as TGF-b also
significantly decreased local HGF production (Fig. 6A). The
inhibitory effect of Ang II in local HGF production was observed
in a dose-dependent manner (Fig. 6B). Similarly, TGF-b signifi-
cantly decreased local HGF secretion from rat endothelial cells
(P , 0.05; Fig. 7).
Cell-cell interactions in renal cells
Given the presence of a local HGF system in renal cells, we
examined the potential role of HGF in the pathophysiology of
Fig. 2. Effect of exogenously added human recombinant hepatocyte
growth factor (HGF) on DNA synthesis in human aortic endothelial cells.
N 5 8 per group. Abbreviations are: DSF, vehicle added to cells; HGF,
human recombinant HGF (0.1 to 100 ng/ml) added to cells. *P , 0.05,
**P , 0.01 versus DSF.
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renal diseases. Initially, we hypothesized that local HGF produc-
tion from mesangial cells may regulate endothelial cells, given that
HGF stimulates endothelial cells, but not mesangial cells (Figs. 1
and 2). Therefore, we studied the effect of conditioned medium
from mesangial cells on other renal cells. In this study, we
employed renal glomerular cells. As shown in Figure 8, incubation
of bovine glomerular endothelial cells (GEN-T) with the condi-
tioned medium from rat mesangial cells resulted in a significant
increase in growth of endothelial cells (P , 0.01). Interestingly,
this accelerated growth was significantly inhibited by co-incuba-
tion with neutralizing anti-rat HGF antibody (P , 0.01). Local
HGF secretion seems to play an important role in the mainte-
nance of renal cell structure. Using a co-culture system, we further
examined this hypothesis that local HGF secretion from mesan-
gial cells maintains endothelial function. Co-culture of rat mes-
angial cells with GEN-T resulted in a significant increase in cell
number (P , 0.02) (Fig. 9). Interestingly, co-incubation of
anti-HGF antibody in the co-culture system of rat mesangial cells
with endothelial cells significantly abolished the mitogenic activity
of conditioned medium from mesangial cells (P , 0.01), but not
completely.
DISCUSSION
The concept of the local control of renal function by locally
synthesized compounds has been recently described. It has been
hypothesized that locally synthesized growth factors (such as
TGF-b, bFGF) and multiple endothelium-derived substances
(PGI2, NO, CNP) also have profound influences on renal function
[4–6, 31]. Moreover, following endothelial injury, locally synthe-
sized cytokines and growth factors contribute to the development
of mesangial growth [32–37]. These local systems appear to be
independently regulated by regional factors and may play impor-
tant physiologic and pathophysiologic roles. Given the importance
of endothelial antiproliferative actions, repair of endothelial cells
may have therapeutic actions against abnormal mesangial growth.
Indeed, co-culture of endothelial cells with mesangial cells re-
sulted in a significant decrease in number of mesangial cells (data
not shown). From this viewpoint, it would be of interest to seek an
endothelial cell-specific growth factor that does not stimulate
growth of mesangial cells. Many growth factors are known to
stimulate endothelial cells. However, few of these growth factors
can distinguish the growth of endothelial cells and mesangial cells.
In this study, we have focused on the potential role of HGF. As
discussed earlier, HGF has many functions on the cells of target
organs including the kidney [13–16]. Our results demonstrated
that HGF can stimulate growth of glomerular endothelial cells,
while it has no mitogenic action on mesangial cell growth (Figs. 1
and 2).
Of importance, the present data revealed the presence of a
local renal HGF system, assessed by RT-PCR and EIA. There-
fore, we examined the regulation of local renal HGF production.
We focused on the interaction of TGF-b and Ang II with local
HGF production, since TGF-b and Ang II have been demon-
strated to be increased in glomerulonephritis and diabetic ne-
phropathy by in situ hybridization and immunohistochemistry
[32–37]. Our present study documented a marked reduction of
Fig. 3. Presence of hepatocyte growth factor
(HGF) mRNA in various renal cells.
Abbreviations are: MC, rat mesangial cells;
NHMC, human mesangial cells; EC, rat
endothelial cells; GEN-T, bovine glomerular
endothelial cells; NC, negative control (no
RNA). Shown is a representative of three
experiments.
Fig. 4. Presence of c-met (HGF receptor) mRNA in various renal cells.
Abbreviations are: HGF, hepatocyte growth factor; MC, rat mesangial
cells; NHMC, human mesangial cells; EC, rat endothelial cells; GEN-T,
bovine glomerular endothelial cells; NC, negative control (no RNA).
Shown is a representative of three experiments.
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local HGF production in mesangial and endothelial cells by
TGF-b and/or Ang II treatment at physiological dosage. The
promoter region of HGF gene contains various binding sites for
transcriptional factors, such as interleukin 6 response elements,
binding sites for NF-IL 6, a TGF-b inhibitory element, and a
cAMP responsive element [38–40]. TGF-b inhibits HGF produc-
tion probably through a TGF-b inhibitory element, although the
exact mechanisms of HGF production are not yet fully under-
stood. On the other hand, the present study demonstrated that
HGF itself is a strong positive regulator of HGF both in endo-
thelial and mesangial cells, since the anti-rat HGF antibodies used
in this study do not cross react with human HGF [27, 28]. These
results suggest the interesting hypothesis that HGF itself may
regulate local HGF production by autoloop-positive feedback,
and work in an autocrine-paracrine manner. The break of this
autocrine-loop, which maintains endothelial cell growth, by
TGF-b and Ang II may result in renal dysfunction. Taken
together, the activation of local TGF-b and renal renin-angioten-
sin system may negatively regulate local HGF production in renal
cells. Indeed, our previous study demonstrated a significant
decrease in local renal HGF level in spontaneously hypertensive
rats as compared to normotensive Wistar-Kyoto rats [41]. Our
present study demonstrated that HGF did not stimulate growth of
mesangial cells despite the presence of c-met. Nevertheless, the
current data also provide evidence that c-met in mesangial cells is
a functional receptor for at least HGF secretion. It is still unclear
Fig. 5. Hepatocyte growth factor (HGF) concentration in medium of rat
mesangial cells treated with Ang II and TGF-b (A). N 5 8 per group.
Abbreviations are: DSF, cells treated with serum-free medium; Ang II,
cells treated with DSF and angiotensin II 1026 M; TGF-b, cells treated
with DSF and transforming growth factor-b 10 ng/ml. Values are ex-
pressed as HGF concentration adjusted for cell number. *P , 0.05, **P ,
0.01 versus cells treated with DSF. (B) Hepatocyte growth factor concen-
tration in medium of rat mesangial cells treated with human recombinant
HGF. N 5 8 per group. Abbreviations are: DSF, cells treated with
serum-free medium; HGF, cells treated with DSF and rat recombinant
HGF (10 ng/ml). Values are expressed as HGF concentration adjusted for
cell number. **P , 0.01 versus cells treated with DSF.
Fig. 6. Hepatocyte growth factor (HGF) concentration in medium of
human mesangial cells treated with angiotensin II (Ang II) and trans-
forming growth factor-b (TGF-b) (A). N 5 8 per group. Abbreviations
are: DSF, cells treated with serum-free medium; Ang II, cells treated with
DSF and Ang II 1026 M; TGF-b, cells treated with DSF and TGF-b 10
ng/ml. Values are expressed as HGF concentration adjusted for cell
number. *P , 0.05, **P , 0.01 versus cells treated with DSF. (B)
Dose-dependent inhibitory effect of Ang II on HGF concentration in
medium of human mesangial cells. N 5 8 per group. Abbreviations are:
DSF, cells treated with serum-free medium (DSF); Ang II, cells treated
with DSF and Ang II 1029 to 1026 M. Values are expressed as HGF
concentration adjusted for cell number. *P , 0.05, **P , 0.01 versus cells
treated with DSF, ##P , 0.01 versus 27.
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why HGF has no effect on growth of mesangial cells despite the
presence of its receptor mRNA. Further studies are necessary for
the analysis of c-met in mesangial cells. In contrast, Harris et al
reported no detectable level of c-met in rat glomerular mesangial
cells by Northern blot [42]. Controversy in the presence of c-met
in mesangial cells may be due to the sensitivity of detectable
methods (Northern blot vs. RT-PCR).
Finally, we investigated the potential physiological role of the
local HGF system. Secretion of local HGF from mesangial cells
provides the new concept that local production of HGF, which
stimulates growth of endothelial cells, but not mesangial cells,
maintains growth of endothelial cells. Therefore, the effects of
local HGF production from mesangial cells were studied using a
co-culture system. Co-culture of mesangial cells with endothelial
cells resulted in a significant increase in number of endothelial
cells, which was abolished by co-incubation with neutralizing
anti-HGF antibody. Since addition of neutralizing anti-HGF
antibody could not completely abolish the mitogenic action of
co-culture with mesangial cells, other substances from mesangial
cells may also work to maintain the cell-cell interactions, in
addition to locally produced HGF. Given that local HGF produc-
tion was negatively regulated by TGF-b and Ang II, a lack of local
HGF may promote the dysfunction of renal cells in renal disease.
Recent findings show that HGF may play an important role in
tissue regeneration [9–12]. Hepatocyte growth factor mRNA and
blood HGF levels increase markedly after unilateral nephrectomy
and in acute renal failure [14, 16]. Administration of recombinant
HGF prevented acute renal failure and accelerated renal regen-
eration in mice treated with HgCl2 and cisplatin [15, 16]. Al-
though systemic HGF may act in tissue regeneration as a humoral
mediator, in addition to autocrine-paracrine local HGF produc-
tion, these results support the hypothesis that systemic HGF is not
sufficient to promote tissue regeneration due to a decrease in
local HGF production. Taken together, dysfunction of cell-cell
regulation in the kidney due to decreased local HGF production
may accelerate the development of renal disease such as glomer-
ulonephritis.
Overall, these results demonstrated the local production of
HGF, which has stimulatory effects on growth of endothelial
cells, but not mesangial cells, and the presence of its specific
receptor, c-met, in renal cells. Local HGF secretion from
mesangial cells may maintain the function of renal glomerular
endothelial cells. Negative regulation of local HGF production
by Ang II and TGF may play an important role in the
pathogenesis of renal disease.
Fig. 7. Hepatocyte growth factor (HGF) concentration in medium of rat
endothelial cells treated with TGF-b. N 5 8 per group. Abbreviations are:
DSF, cells treated with serum-free medium; TGF-b, cells treated with
DSF and TGF-b (10 ng/ml). Values are expressed as HGF concentration
adjusted for cell number. **P , 0.01 versus cells treated with DSF.
Fig. 8. Increased glomerular endothelial cell (GEN-T) growth by addi-
tion of conditioned medium from rat mesangial cells. N 5 8 per group.
Abbreviations are: CM (2), endothelial cells without conditioned medium
from mesangial cells; CM (1), endothelial cells with conditioned medium
from mesangial cells; 1 control IgG, cells treated with control IgG; 1
HGF-Ab, cells treated with neutralizing anti-HGF antibody. **P , 0.01
versus CM (2).
Fig. 9. Increased glomerular endothelial cell (GEN-T) growth by co-
culture with rat mesangial cells. N 5 8 per group. Abbreviations are: MC
(2), endothelial cells without co-culture with mesangial cells; MC (1)
endothelial cells co-cultured with mesangial cells; 1 control IgG, cells
treated with control IgG; 1 HGF-Ab, cells treated with neutralizing
anti-HGF antibody. **P , 0.01 versus MC (2) 1.
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APPENDIX
Abbreviations used in this paper are: HGF, hepatocyte growth factor;
c-met, specific receptor of HGF; rHGF, recombinant HGF; Ang II,
angiotensin II; TGF-B, transforming growth factor beta; GEN-T, bovine
glomerular endothelial cells; NHMC, human mesangial cells; DMEM,
Dulbecco’s modified Eagle’s medium; LDL, low density lipoprotein; DSF,
serum-free medium; MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5,-diphenyl tet-
razolium bromide; FCS, fetal calf serum; PBS, phosphate buffered saline.
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